Combination HIV-Specific bnAbs Combined with ART Initiation during Acute HIV Infection
Official Title
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined with ART Initiation during Acute HIV Infection to Induce HIV Remission
Purpose
The purpose of this study is to evaluate the safety and efficacy of combination bNAbs in addition to ART initiated during acute HIV infection and to evaluate the impact on HIV viral reservoirs.
Could this study be right for you?
- Newly diagnosed HIV+ individuals who have not yet started antiretroviral therapy (ART)
- Willingness to start ART at enrollment
- Ability and willingness to participate in scheduled study visits and analytic treatment interruption (ATI)
- Weight <115kg